Prof. Dr. Victor J. Dzau, M.D., is President of the US National Academy of Medicine (NAM) and Co-Chair of the US National Research Council. He is Chancellor Emeritus and James B. Duke Distinguished Professor of Medicine at Duke University and past CEO of Duke Health. Previously, he was Chairman of Medicine at Harvard and Stanford Universities. Professor Dzau is highly regarded as a trailblazer in translational research, health innovation, and global health. His seminal research laid the foundation for development of lifesaving drugs known as ACE inhibitors, used globally to treat hypertension and heart failure. Professor Dzau pioneered gene therapy for vascular disease. As one of the world’s preeminent health leaders, he has served as Chair of the NIH Cardiovascular Disease Advisory Committee and currently chairs their Progenitor Cell Translational Consortium. A leader in global health, Dzau launched the Duke Global Health Institute and Duke-NUS Medical School in Singapore. He serves on the WHO/World Bank Global Preparedness Monitoring Board, was advisor to the G20 High Level Panel on Financing for Pandemics, co-chaired the G20 Scientific Panel on Global Health Security, and is an advisor to the G7 Japan Health Task Force. As inaugural president of the NAM, he leads a strategy of innovation and equity. Under his tenure, the NAM has launched important initiatives including the Global Health Risk Framework, Human Genome Editing Initiative, Global Roadmap for Healthy Longevity, and Grand Challenge in Climate Change, Health, and Equity.
